Prion properties of SOD1 in amyotrophic lateral sclerosis and potential therapy

Cold Spring Harbor Perspectives in Biology

Volumn 9, Issue 10, 2017, Pages

  Sibilla, Caroline ^a   Bertolotti, Anne ^a  

^a MRC LABORATORY OF MOLECULAR BIOLOGY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

COPPER ZINC SUPEROXIDE DISMUTASE; SOD1 PROTEIN, HUMAN;

AMYOTROPHIC LATERAL SCLEROSIS; HUMAN; METABOLISM; PRION;

AMYOTROPHIC LATERAL SCLEROSIS; HUMANS; PRIONS; SUPEROXIDE DISMUTASE-1;

EID: 85030715828     PISSN: None     EISSN: 19430264     Source Type: Journal    
DOI: 10.1101/cshperspect.a024141     Document Type: Article

References (60)

1. Ayers JI, Fromholt S, Koch M, DeBosier A, McMahon B, Xu G, Borchelt DR. 2014. Experimental transmissibility of mutant SOD1 motor neuron disease. Acta Neuropathol 128: 791–803.
2. Bettencourt C, Houlden H. 2015. Exome sequencing uncovers hidden pathways in familial and sporadic ALS. Nat Neurosci 18: 611–613.
3. Bidhendi EE, Bergh J, Zetterstrӧm P, Andersen PM, Marklund SL, Brӓnnstrӧm T. 2016. Two superoxide dismutase prion strains transmit amyotrophic lateral sclerosis-like disease. J Clin Invest 126: 2249–2253.
4. Bousset L, Pieri L, Ruiz-Arlandis G, Gath J, Jensen PH, Habenstein B, Madiona K, Olieric V, Bӧckmann A, Meier BH, et al. 2013. Structural and functional characterization of two a-synuclein strains. Nat Commun 4: 2575.
5. Charcot JM. 1890. Lecons sur les maladies due systeme nerveux, 3 Vols. Bureau du Progres Medical, Paris, 1894.
6. Chattopadhyay M, Durazo A, Sohn SH, Strong CD, Gralla EB, Whitelegge JP, Valentine JS. 2008. Initiation and elongation in fibrillation of ALS-linked superoxide dismutase. Proc Natl Acad Sci 105: 18663–18668.
7. Clavaguera F, Bolmont T, Crowther RA, Abramowski D, Frank S, Probst A, Fraser G, Stalder AK, Beibel M, Staufenbiel M, et al. 2009. Transmission and spreading of tauopathy in transgenic mouse brain. Nat Cell Biol 11: 909–913.
8. Clavaguera F, Akatsu H, Fraser G, Crowther RA, Frank S, Hench J, Probst A, Winkler DT, Reichwald J, Staufenbiel M, et al. 2013. Brain homogenates from human tauopathies induce τ inclusions in mouse brain. Proc Natl Acad Sci 110: 9535–9540.
9. Danzer KM, Haasen D, Karow AR, Moussaud S, Habeck M, Giese A, Kretzschmar H, Hengerer B, Kostka M. 2007. Different species of α-synuclein oligomers induce calcium influx and seeding. J Neurosci 27: 9220–9232.
10. Danzer KM, Krebs SK, Wolff M, Birk G, Hengerer B. 2009. Seeding induced by α -synuclein oligomers provides evidence for spreading of α -synuclein pathology. J Neurochem 111: 192–203.
11. Das I, Krzyzosiak A, Schneider K, Wrabetz L, D’Antonio M, Barry N, Sigurdardottir A, Bertolotti A. 2015. Preventing proteostasis diseases by selective inhibition of a phosphatase regulatory subunit. Science 348: 239–242.
12. Desplats P, Lee HJ, Bae EJ, Patrick C, Rockenstein E, Crews L, Spencer B, Masliah E, Lee SJ. 2009. Inclusion formation and neuronal cell death through neuron-to-neuron transmission of α -synuclein. Proc Natl Acad Sci 106: 13010–13015.
13. Eisenberg D, Jucker M. 2012. The amyloid state of proteins in human diseases. Cell 148: 1188–1203.
14. Frost B, Jacks RL, Diamond MI. 2009. Propagation of tau misfolding from the outside to the inside of a cell. J Biol Chem 284: 12845–12852.
15. Gowers WR. 1892. Manual of diseases of the nervous system, Vol. 1. J& A Churchill, London.
16. Grad LI, Guest WC, Yanai A, Pokrishevsky E, O’Neill MA, Gibbs E, Semenchenko V, Yousefi M, Wishart DS, Plotkin SS, Cashman NR. 2011. Intermolecular transmission of superoxide dismutase 1 misfolding in living cells. Proc Natl Acad Sci 108: 16398–16403.
17. Grad LI, Yerbury JJ, Turner BJ, Guest WC, Pokrishevsky E, O’Neill MA, Yanai A, Silverman JM, Zeineddine R, Corcoran L, et al. 2014. Intercellular propagated misfolding of wild-type Cu/Zn superoxide dismutase occurs via exosome-dependent and -independent mechanisms. Proc Natl Acad Sci 111: 3620–3625.
18. Gurney ME, Pu H, Chiu AY, Dal Canto MC, Polchow CY, Alexander DD, Caliendo J, Hentati A, Kwon YW, Deng HX, et al. 1994.Motor neuron degeneration in mice that express a human Cu, Zn superoxide dismutase mutation. Science 264: 1772–1775.
19. Hall AH. 1985. Guanabenz overdose. Ann Intern Med 102: 787–788.
20. Holmes B, Brogden RN, Heel RC, Speight TM, Avery GS. 1983. Guanabenz. A review of its pharmacodynamic properties and therapeutic efficacy in hypertension. Drugs 26: 212–229.
21. Holmes BB, DeVos SL, Kfoury N, Li M, Jacks R, Yanamandra K, Ouidja MO, Brodsky FM, Marasa J, Bagchi DP, et al. 2013. Heparan sulfate proteoglycans mediate internalization and propagation of specific proteopathic seeds. Proc Natl Acad Sci 110: E3138–E3147.
22. Johnston JA, Dalton MJ, Gurney ME, Kopito RR. 2000. Formation of high molecular weight complexes of mutant Cu, Zn-superoxide dismutase in a mouse model for familial amyotrophic lateral sclerosis. Proc Natl Acad Sci 97: 12571–12576.
23. Jousse C, Oyadomari S, Novoa I, Lu P, Zhang Y, Harding HP, Ron D. 2003. Inhibition of a constitutive translation initiation factor 2α phosphatase,CReP, promotes survival of stressed cells. J Cell Biol 163: 767–775.
24. Jucker M, Walker LC. 2011. Pathogenic protein seeding in Alzheimer disease and other neurodegenerative disorders. Ann Neurol 70: 532–540.
25. Kane MD, Lipinski WJ, Callahan MJ, Bian F, Durham RA, Schwarz RD, Roher AE, Walker LC. 2000. Evidence for seeding of β-amyloid by intracerebral infusion of Alzheimer brain extracts in β-amyloid precursor proteintransgenic mice. J Neurosci 20: 3606–3611.
26. Kiernan MC, Vucic S, Cheah BC, Turner MR, Eisen A, Hardiman O, Burrell JR, Zoing MC. 2011. Amyotrophic lateral sclerosis. Lancet 377: 942–955.
27. Kojima E, Takeuchi A, Haneda M, Yagi A, Hasegawa T, Yamaki K, Takeda K, Akira S, Shimokata K, Isobe K. 2003. The function of GADD34 is a recovery from a shutoff of protein synthesis induced by ER stress: Elucidation by GADD34-deficient mice. FASEB J 17: 1573–1575.
28. Li JY, Englund E, Holton JL, Soulet D, Hagell P, Lees AJ, Lashley T, Quinn NP, Rehncrona S, Björklund A, et al. 2008. Lewy bodies in grafted neurons in subjects with Parkinson’s disease suggest host-to-graft disease propagation. Nat Med 14: 501–503.
29. Luk KC, Kehm V, Carroll J, Zhang B, O’Brien P, Trojanowski JQ, Lee VM. 2012. Pathological α-synuclein transmission initiates Parkinson-like neurodegeneration in nontransgenic mice. Science 338: 949–953.
30. Meyer-Luehmann M, Coomaraswamy J, Bolmont T, Kaeser S, Schaefer C, Kilger E, Neuenschwander A, Abramowski D, Frey P, Jaton AL, et al. 2006. Exogenous induction of cerebral β-amyloidogenesis is governed by agent and host. Science 313: 1781–1784.
31. Morimoto RI, Cuervo AM. 2014. Proteostasis and the aging proteome in health and disease. J Gerontol A Biol Sci Med Sci 69: S33–S38.
32. Münch C, Bertolotti A. 2010. Exposure of hydrophobic surfaces initiates aggregation of diverse ALS-causing superoxide dismutase-1 mutants./Mol Biol 399: 512-525.
33. Münch C, Bertolotti A. 2011. Self-propagation and transmission of misfolded mutant SOD1: Prion or prion-like phenomenon? Cell Cycle 10: 1711.
34. Münch C, Bertolotti A. 2012. Propagation of the prion phenomenon: Beyond the seeding principle./Mol Biol 421: 491-498.
35. Munch C, O’Brien J, Bertolotti A. 2011. Prion-like propagation of mutant superoxide dismutase-1 misfolding in neuronal cells. Proc Natl Acad Sci 108: 3548-3553.
36. Neumann M, Sampathu DM, Kwong LK, Truax AC, Micsenyi MC, Chou TT, Bruce J, Schuck T, Grossman M, Clark CM, et al. 2006. Ubiquitinated TDP-43 in fronto-temporal lobar degeneration and amyotrophic lateral sclerosis. Science 314: 130-133.
37. Nordlund A, Oliveberg M. 2008. SOD 1-associated ALS: A promising system for elucidating the origin of protein-misfolding disease. HFSP J 2: 354-364.
38. Novoa I, Zeng H, Harding HP, Ron D. 2001. Feedback inhibition of the unfolded protein response by GADD34-mediated dephosphorylation of eIF2α. j Cell Biol 153: 1011-1022.
39. Prusiner SB. 1998. Prions. Proc Natl Acad Sci 95: 13363-13383.
40. Prusiner SB. 2012. Cell biology. A unifying role for prions in neurodegenerative diseases. Science 336: 1511-1513.
41. Prusiner SB, Woerman AL, Mordes DA, Watts JC, Rampersaud R, Berry DB, Patel S, Oehler A, Lowe JK, Kravitz SN, et al. 2015. Evidence for a-synuclein prions causing multiple system atrophy in humans with parkinsonism. Proc Natl Acad Sci 112: E5308-E5317.
42. Ravits JM, La Spada AR. 2009. ALS motor phenotype heterogeneity, focality, and spread: Deconstructing motor neuron degeneration. Neurology 73: 805-811.
43. Reaume AG, Elliott JL, Hoffman EK, Kowall NW, Ferrante RJ, Siwek DF, Wilcox HM, Flood DG, Beal MF, Brown RJ, et al. 1996. Motor neurons in Cu/Zn superoxide dismutase-deficient mice develop normally but exhibit enhanced cell death after axonal injury. Nat Genet 13: 43-47.
44. Ren PH, Lauckner JE, Kachirskaia I, Heuser JE, Melki R, Kopito RR. 2009. Cytoplasmic penetration and persistent infection of mammalian cells by polyglutamine aggregates. Nat Cell Biol 11: 219-225.
45. Ron D, Harding HP. 2007. eIF2a phosphorylation in cellular stress responses and disease. In Translational control in biology and medicine (ed. Mathews MB, et al.), Cold Spring Harbor Monograph Series, pp. 345-368. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
46. Rosen DR, Siddique T, Patterson D, Figlewicz DA, Sapp P, Hentati A, Donaldson D, Goto J, O’Regan JP, Deng HX, et al. 1993. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 364: 362.
47. Rotunno MS, Bosco DA. 2013. An emerging role for misfolded wild-type SOD1 in sporadic ALS pathogenesis. Front Cell Neurosci doi: 10.3389/fncel.2013.00253
48. Sanders DW, Kaufman SK, DeVos SL, Sharma AM, Mirbaha H, Li A, Barker SJ, Foley AC, Thorpe JR, Serpell LC, et al. 2014. Distinct tau prion strains propagate in cells and mice and define different tauopathies. Neuron 82: 1271-1288.
49. Schneider K, Bertolotti A. 2015. Surviving protein quality control catastrophes—From cells to organisms./Cell Sci 128: 3861-3869.
50. Shaw BF, Valentine JS. 2007. How do ALS-associated mutations in superoxide dismutase 1 promote aggregation of the protein? Trends Biochem Sci 32: 78-85.
51. Tsaytler R Harding HP, Ron D, Bertolotti A. 2011. Selective inhibition of a regulatory subunit of protein phosphatase 1 restores proteostasis. Science 332: 91-94.
52. Valentine JS, Doucette PA, Zittin Potter S. 2005. Copperzinc superoxide dismutase and amyotrophic lateral sclerosis. Annu Rev Biochem 74: 563-593.
53. Vilchez D, Saez I, Dillin A. 2014. The role of protein clearance mechanisms in organismal ageing and age-related diseases. Nat Commun 5: 5659.
54. Wang J, Farr GW, Zeiss CJ, Rodriguez-Gil DJ, Wilson JH, Furtak K, Rutkowski DT, Kaufman RJ, Ruse Cl, Yates JR, et al. 2009. Progressive aggregation despite chaperone associations of a mutant SOD1-YFP in transgenic mice that develop ALS. Proc Natl Acad Sci 106: 1392-1397.
55. Wang L, Popko B, Roos RP. 2011. The unfolded protein response in familial amyotrophic lateral sclerosis. Hum Mol Genet 20: 1008-1015.
56. Wang L, Popko B, Roos RP. 2014. An enhanced integrated stress response ameliorates mutant SOD 1-induced ALS. Hum Mol Genet 23: 2629-2638.
57. Watts JC, Condello C, Stohr J, Oehler A, Lee J, DeArmond SJ, Lannfelt L, Ingelsson M, Giles K, Prusiner SB. 2014. Serial propagation of distinct strains of Aβ prions from Alzheimer’s disease patients. Proc Natl Acad Sci 111: 10323-10328.
58. Weser U, Miesel R, Hartmann HJ. 1989. Mummified enzymes. Nature 341: 696.
59. Yanamandra K, Kfoury N, Jiang H, Mahan TE, Ma S, Maloney SE, Wozniak DF, Diamond MI, Holtzman DM. 2013. Anti-tau antibodies that block tau aggregate seeding in vitro markedly decrease pathology and improve cognition in vivo. Neuron 80: 402-414.
60. Zeineddine R, Pundavela JF, Corcoran L, Stewart EM, Do-Ha D, Bax M, Guillemin G, Vine KL, Hatters DM, Ecroyd H, et al. 2015. SOD1 protein aggregates stimulate macro-pinocytosis in neurons to facilitate their propagation. Mol Neurodegener 10: 57-1-57-18.